Denali Therapeutics Inc. · NASDAQ:DNLI
Capital Research Global Investors's stake in Denali Therapeutics Inc. fell to 3.80% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Capital Research Global Investors's stake in Denali Therapeutics Inc. fell to 3.80%, 5,477,211 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 3.80%
- Shares
- 5,477,211
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital Research Global Investors | 3.80% | 5,477,211 |